Your browser doesn't support javascript.
loading
Development of a quantitative approach in blood plasma for low-dosed hallucinogens and opioids using LC-high resolution mass spectrometry.
Caspar, Achim T; Kollas, Andreas B; Maurer, Hans H; Meyer, Markus R.
Afiliación
  • Caspar AT; Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, Germany.
  • Kollas AB; Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, Germany.
  • Maurer HH; Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, Germany.
  • Meyer MR; Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, Germany. Electronic address: markus.meyer@uks.eu.
Talanta ; 176: 635-645, 2018 Jan 01.
Article en En | MEDLINE | ID: mdl-28917801

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fenetilaminas / Fentanilo / Alucinógenos / Analgésicos Opioides / Dietilamida del Ácido Lisérgico Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Talanta Año: 2018 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fenetilaminas / Fentanilo / Alucinógenos / Analgésicos Opioides / Dietilamida del Ácido Lisérgico Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Talanta Año: 2018 Tipo del documento: Article País de afiliación: Alemania